A phase 1 clinical study of influenza vaccine - Emergex Vaccines
Latest Information Update: 06 Dec 2024
At a glance
- Drugs Influenza vaccine Emergex Vaccines (Primary)
- Indications Influenza A virus infections
- Focus Adverse reactions
Most Recent Events
- 17 Oct 2024 According to Emergex Vaccines media release, Emergex Vaccines has changed its name to Gylden Pharma Limited.
- 22 Aug 2024 According to Emergex Vaccines media release, Emergex is set to advance its first-in-class influenza vaccine into the clinic, with Phase I trials anticipated to begin in the first half of 2025.
- 15 Jan 2020 New trial record